Latest News Archive
Please select Category, Year, and then Month to display items
08 May 2024
|
Story Anthony Mthembu
|
Photo SUPPLIED
From left to right: Prof Philippe Burger, Dean of the Faculty of Economic and Management Sciences (EMS) at the University of the Free State (UFS), presenting an award to Ntswaki Moshwaisi.
A cohort of esteemed academic and support staff from the Faculty of Economic and Management Sciences (EMS) at the University of the Free State (UFS), received well-deserved accolades at the 2024 annual EMS Awards. Notable among them were Programme Coordinator Ntswaki Moshwaisi and Associate Professor Prof Liezel Massyn from the UFS Business School.
Prof Massyn was lauded in the Teaching and Learning category, while Moshwaisi garnered recognition in the Support Staff category at the awards ceremony held on 18 April 2024, on the UFS Bloemfontein campus.
Reflecting on her achievement, Moshwaisi expressed gratitude, stating, “The award serves as motivation to myself to keep working hard and to innovate methods and approaches towards my work.’’
The significance of the awards
Prof Massyn remarked that the awards serve to spotlight the remarkable contributions of both academics and support staff within the faculty. She considers the award as a testament to her dedication, acknowledged by her esteemed colleagues. Both Prof Massyn and Moshwaisi attribute their success to the support they receive from their peers.
Moreover, they emphasise that these awards transcend mere recognition. It will serve as an impetus to the way forward. Moshwaisi envisages leveraging her award to enhance the quality and efficacy of the programmes under her stewardship. Prof Massyn, echoing this statement, asserts, ’’It will strengthen my belief in the transformative power of teaching and make me work harder to provide quality learning opportunities to students. I am a firm believer in following an evidence-based approach and will continue to research learning and teaching.’’
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”